Taigen Biotechnology
Latest round
- Series C
Last raised
- Jan 2009
Total raised
- $75M
Investors
- 5
About Taigen Biotechnology
Based in Taipei, China, and founded in 2001, Taigen Biotechnology operates as a research-based and product-driven pharmaceutical company, dedicated to the development of anti-infective drugs. The company has set up a branch office in Beijing. There are 70 employees in the company, and 80% of them are the research and development staff. The CEO, Guolong Huang, worked at Sandoz, Novartis AG. The company specializes in the development of drugs for anti-infective diseases. Its main products are TG-1000, Burixafor, NEMONOXACIN, and Flarevir. NEMONOXACIN is effective against drug-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), penicillin-resistant Streptococcus pneumoniae (PRSP), and AB bacteria. Furaprevir can work against 6 genotypes of the hepatitis C virus. The drugs can be used in the treatment of liver disease, infectious diseases, and tumors.
Who invested in Taigen Biotechnology
5 investors across 2 rounds
See all investors in Taigen Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Taigen Biotechnology
Who invested in Taigen Biotechnology?
Taigen Biotechnology has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Taigen Biotechnology raised?
Taigen Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Taigen Biotechnology last raise money?
Taigen Biotechnology's most recent round on record is a Series C, in Jan 2009.
What does Taigen Biotechnology do?
Based in Taipei, China, and founded in 2001, Taigen Biotechnology operates as a research-based and product-driven pharmaceutical company, dedicated to the development of anti-infective drugs.
Where is Taigen Biotechnology headquartered?
Taigen Biotechnology is headquartered in Taipei, Taiwan - China.
Which VCs invest in companies like Taigen Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Taigen Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Taigen Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.